MYB and B-cell chronic lymphocytic leukemia: In this report, they identified MYB binding sites onto the MIR155HG promoter near the TSS in primary B-CLL, resulting in the dysregulation of miR-155’s epigenetic status and its aberrantly elevated levels in CLL [120].